From the Desk of Kimmy Sokoloff

That was a nice pop this morning, with $SPY trading as high as 404.

I put on a long position in SPY last night at 401. So it was a nice and very welcome good-morning gift.

Today's Hot List is another short one.

The only 13G on our list was filed by Pura Vida Investments LLC, which revealed an initial stake of 5.62% in Quanterix Corporation $QTRX.

From the Desk of Kimmy Sokoloff

The market is back to happy mode.

$SPY is trading above 400, and all is well.

From the Desk of Kimmy Sokoloff

This morning $SPY broke below its 200-day moving average at 395.50 and then managed to come back above it.

It shrugged off $MSFT’s earnings report last night.

I call it the comeback kid! 

From the Desk of Steve Strazza @Sstrazza

When investing in the stock market, we always want to approach it as "a market of stocks."

Regardless of the environment, there are always stocks showing leadership and trending higher.

We may have to look harder to identify them depending on current market conditions. But there are always stocks that are going up.

The same can be said for weak stocks. Regardless of the environment, there are always stocks that are going down, too. 

We already have multiple scans focusing on stocks making all-time highs, such as The Hall of Famers, The Minor Leaguers, and The 2 to 100 Club.

We filter these universes for stocks with the best momentum and relative strength characteristics. 

Clearly, we spend a lot of time identifying and writing about leading stocks every week via multiple reports.

Now, we're also highlighting lagging stocks on a recurring basis.

Welcome to the Short Report.

We publish this...

The largest insider buy on today's list is a Form 4 filing by RA Capital Management.

The hedge fund reported a purchase of roughly $25 million in Fulcrum Therapeutics Inc $FULC, increasing its ownership stake to 23.8%.

From the Desk of Kimmy Sokoloff

$MSFT reported last night, and, at first, it rallied above $250. And then management had their conference call.

We'll see how it acts, if dip-buyers show up or it just heads back down to $226.

From the Desk of Kimmy Sokoloff

There was a major glitch at the New York Stock Exchange today, and it really did a number on the opening of the market.

Prices were all over the place, and names were halted.

Three of my positions below went to my target. But due to the glitch they won't get filled today, which they really should.

It was a day to step aside.

From the Desk of Steve Strazza @Sstrazza

Last week we held our January Monthly Conference Call, which Premium Members can access and rewatch here.

In this post, we’ll do our best to summarize it by highlighting five of the most important charts and/or themes we covered, along with commentary on each

Let’s get right into it!

With stocks off to a very strong start to the year, we're certainly setting ourselves up for a positive January.

There is still about a week left, but the S&P500 is already up 4.7% so far this month.

Historically, if we finish up, and it looks like the chances of that are high, then it bodes very well for stocks throughout the rest of the year.

The largest insider buy on today's list is a Form 4 filing by EcoR1 Capital LLC, which reported a purchase of roughly $2.9 million in Zymeworks Inc $ZYME.

EcoR1 Capital also filed a Form 13G, disclosing a stake of 7.80% in the cancer biotech stock Janux Therapeutics $JANX.

From the Desk of Kimmy Sokoloff

The futures are indicating lower this morning. A healthy digesting is warranted.

I'd like to see 396, roughly, held over the next few days on $SPY.

If we push past 402.70, then we can potentially see 405, the next level above.